Mast cell-orchestrated immunity to pathogens

Nature Reviews Immunology

Volumn 10, Issue 6, 2010, Pages 440-452

  Abraham, Soman N ^a,b   St John, Ashley L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CELL COMMUNICATION; CELL FUNCTION; CELL MIGRATION; CYTOLOGY; DEGRANULATION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPH NODE; MAST CELL; NONHUMAN; PARASITOSIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIZATION; VACCINATION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; CELL MOVEMENT; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MAST CELLS; VACCINATION;

EID: 77952868792     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2782     Document Type: Review

References (100)

1. McNeil, H. P., Adachi, R. & Stevens, R. L. Mast cell-restricted tryptases: structure and function in inflammation and pathogen defense. J. Biol. Chem. 282, 20785-20789 (2007).
2. Woodbury, R. G. et al. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature 312, 450-452 (1984).
3. Nawa, Y., Kiyota, M., Korenaga, M. & Kotani, M. Defective protective capacity of W/Wv mice against Strongyloides ratti infection and its reconstitution with bone marrow cells. Parasite Immunol. 7, 429-438 (1985).
4. Abraham, S. N. & Malaviya, R. Mast cells in infection and immunity. Infect. Immun. 65, 3501-3508 (1997).
5. Abe, T., Swieter, M., Imai, T., Hollander, N. D. & Befus, A. D. Mast cell heterogeneity: two-dimensional gel electrophoretic analyses of rat peritoneal and intestinal mucosal mast cells. Eur. J. Immunol. 20, 1941-1947 (1990).
6. Vliagoftis, H. & Befus, A. D. Rapidly changing perspectives about mast cells at mucosal surfaces. Immunol. Rev. 206, 190-203 (2005).
7. Metcalfe, D. D., Baram, D. & Mekori, Y. A. Mast cells. Physiol. Rev. 77, 1033-1079 (1997).
8. Welle, M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J. Leukoc. Biol. 61, 233-245 (1997).
9. Ghildyal, N., McNeil, H. P., Gurish, M. F., Austen, K. F. & Stevens, R. L. Transcriptional regulation of the mucosal mast cell-specific protease gene, MMCP-2, by interleukin 10 and interleukin 3. J. Biol. Chem. 267, 8473-8477 (1992).
10. Toru, H. et al. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 91, 187-195 (1998).
11. Oskeritzian, C. A. et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J. Allergy Clin. Immunol. 11 5, 1162-1168 (2005).
12. Burke, S. M. et al. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111, 5467-5476 (2008).
13. Burwen, S. J. Recycling of mast cells following degranulation in vitro: an ultrastructural study. Tissue Cell 14, 125-134 (1982).
14. Trinchieri, G. & Sher, A. Cooperation of Toll-like receptor signals in innate immune defence. Nature Rev. Immunol. 7, 179-190 (2007).
15. Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109, 1351-1359 (2002).
16. Varadaradjalou, S. et al. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906 (2003).
17. Malaviya, R., Gao, Z., Thankavel, K., van der Merwe, P. A. & Abraham, S. N. The mast cell tumor necrosis factor α response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl Acad. Sci. USA 96, 8110-8115 (1999).
18. Munoz, S., Hernandez-Pando, R., Abraham, S. N. & Enciso, J. A. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J. Immunol. 170, 5590-5596 (2003).
19. Rocha-de-Souza, C. M., Berent-Maoz, B., Mankuta, D., Moses, A. E. & Levi-Schaffer, F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor α release and the role of Toll-like receptor 2 and CD48 molecules. Infect. Immun. 76, 4489-4497 (2008).
20. Kawakami, T. & Galli, S. J. Regulation of mast-cell and basophil function and survival by IgE. Nature Rev. Immunol. 2, 773-786 (2002).
21. Woolhiser, M. R., Okayama, Y., Gilfillan, A. M. & Metcalfe, D. D. IgG-dependent activation of human mast cells following up-regulation of FcγRI by IFN-γ. Eur. J. Immunol. 31, 3298-3307 (2001).
22. Gurish, M. F. et al. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J. Immunol. 172, 1139-1145 (2004).
23. Qiao, H., Andrade, M. V., Lisboa, F. A., Morgan, K. & Beaven, M. A. FcεR1 and Toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 107, 610-618 (2006).
24. Genovese, A. et al. Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect. Immun. 68, 5517-5524 (2000).
25. Hirai, Y. et al. A new mast cell degranulating peptide "mastoparan" in the venom of Vespula lewisii. Chem. Pharm. Bull. (Tokyo) 27, 1942-1944 (1979). (Pubitemid 10223843)
26. Demeure, C. E. et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J. Immunol. 174, 3932-3940 (2005).
27. Johnson, D. & Krenger, W. Interactions of mast cells with the nervous system\recent advances. Neurochem. Res. 17, 939-951 (1992).
28. Maurer, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512-516 (2004).
29. Nilsson, G. et al. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157, 1693-1698 (1996).
30. Mullaly, S. C. & Kubes, P. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur. J. Immunol. 37, 224-234 (2007).
31. Ehrlich, P. Nobel Lecture, December 11, 1908 (Elsevier, Amsterdam, 1967).
32. Kunder, C. A. et al. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J. Exp. Med. 206, 2455-2467 (2009).
33. Thakurdas, S. M. et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 282, 20809-20815 (2007).
34. Huang, C. et al. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160, 1910-1919 (1998). (Pubitemid 28106480)
35. Tani, K. et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J. Leukoc. Biol. 67, 585-589 (2000).
36. Shin, K. et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180, 4885-4891 (2008).
37. Piliponsky, A. M. et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nature Med. 14, 392-398 (2008).
38. Kalesnikoff, J. & Galli, S. J. New developments in mast cell biology. Nature Immunol. 9, 1215-1223 (2008).
39. Galli, S. J., Nakae, S. & Tsai, M. Mast cells in the development of adaptive immune responses. Nature Immunol. 6, 135-142 (2005).
40. Benyon, R. C., Robinson, C. & Church, M. K. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br. J. Pharmacol. 97, 898-904 (1989).
41. Boyce, J. A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 217, 168-185 (2007).
42. Datta, Y. H. et al. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation 92, 3304-3311 (1995).
43. McIntyre, T. M., Zimmerman, G. A. & Prescott, S. M. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc. Natl Acad. Sci. USA 83, 2204-2208 (1986).
44. Malaviya, R. & Abraham, S. N. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67, 841-846 (2000).
45. Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875 (2001).
46. Caron, G. et al. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J. Immunol. 166, 6000-6006 (2001).
47. Nakano, N. et al. Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 109, 4846-4855 (2007).
48. Malaviya, R., Ikeda, T., Ross, E. & Abraham, S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77-80 (1996).
49. Shelburne, C. P. et al. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 6, 331-342 (2009).
50. + T-cell recruitment. Blood 106, 978-987 (2005).
51. Ketavarapu, J. M. et al. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc. Natl Acad. Sci. USA 105, 9313-9318 (2008).
52. Sutherland, R. E., Olsen, J. S., McKinstry, A., Villalta, S. A. & Wolters, P. J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J. Immunol. 181, 5598-5605 (2008).
53. Orinska, Z. et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nature Med. 13, 927-934 (2007).
54. Grimbaldeston, M. A., Nakae, S., Kalesnikoff, J., Tsai, M. & Galli, S. J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunol. 8, 1095-1104 (2007).
55. Palker, T. J., Dong, G. & Leitner, W. W. Mast cells in innate and adaptive immunity to infection. Eur. J. Immunol. 40, 13-18 (2010).
56. Peranteau, W. H. et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J. Invest. Dermatol. 128, 1852-1860 (2008).
57. Boesiger, J. et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcε receptor I expression. J. Exp. Med. 188, 1135-1145 (1998).
58. Sendo, T. et al. Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cell Signal 15, 773-781 (2003).
59. Heltianu, C., Simionescu, M. & Simionescu, N. Histamine receptors of the microvascular endothelium revealed in situ with a histamine-ferritin conjugate: characteristic high-affinity binding sites in venules. J. Cell Biol. 93, 357-364 (1982).
60. Gordon, J. R. & Galli, S. J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346, 274-276 (1990).
61. Biedermann, T. et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192, 1441-1452 (2000).
62. Di Nardo, A., Vitiello, A. & Gallo, R. L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278 (2003).
63. Margulis, A. et al. Mast cell-dependent contraction of human airway smooth muscle cell-containing collagen gels: influence of cytokines, matrix metalloproteases, and serine proteases. J. Immunol. 183, 1739-1750 (2009).
64. Klimpel, G. R. et al. A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin. J. Exp. Med. 182, 1931-1942 (1995).
65. Pothoulakis, C., Castagliuolo, I. & LaMont, J. T. Nerves and intestinal mast cells modulate responses to enterotoxins. News Physiol. Sci. 13, 58-63 (1998)
66. Bischoff, S. C. Physiological and pathophysiological functions of intestinal mast cells. Semin. Immunopathol. 31, 185-205 (2009).
67. McLachlan, J. B. et al. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nature Immunol. 4, 1199-1205 (2003).
68. Jawdat, D. M., Rowden, G. & Marshall, J. S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 177, 1755-1762 (2006).
69. Amaral, M. M. et al. Histamine improves antigen uptake and cross-presentation by dendritic cells. J. Immunol. 179, 3425-3433 (2007).
70. Mazzoni, A., Siraganian, R. P., Leifer, C. A. & Segal, D. M. Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J. Immunol. 177, 3577-3581 (2006).
71. + T cell effector functions. Immunity 31, 665-676 (2009).
72. Knight, P. A., Wright, S. H., Lawrence, C. E., Paterson, Y. Y. & Miller, H. R. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192, 1849-1856 (2000).
73. Mekori, Y. A. & Metcalfe, D. D. Mast cell-T cell interactions. J. Allergy Clin. Immunol. 104, 517-523 (1999).
74. Echtenacher, B., Mannel, D. N. & Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (1996).
75. Wei, O. L., Hilliard, A., Kalman, D. & Sherman, M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect. Immun. 73, 1978-1985 (2005).
76. Ohnmacht, C. & Voehringer, D. Basophils protect against reinfection with hookworms independently of mast cells and memory Th2 cells. J. Immunol. 184, 344-350 (2010).
77. Maurer, M. et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J. 20, 2460-2467 (2006).
78. Newlands, G. F., Coulson, P. S. & Wilson, R. A. Stem cell factor dependent hyperplasia of mucosal-type mast cells but not eosinophils in Schistosoma mansoni-infected rats. Parasite Immunol. 17, 595-598 (1995).
79. Asai, K. et al. Regulation of mast cell survival by IgE. Immunity 14, 791-800 (2001).
80. W-sh/W-sh mice. Am. J. Pathol. 176, 926-938 (2010).
81. Siebenhaar, F. et al. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am. J. Pathol. 170, 1910-1916 (2007).
82. Wershil, B. K., Castagliuolo, I. & Pothoulakis, C. Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 114, 956-964 (1998).
83. Sugiyama, K. Histamine release from rat mast cells induced by Sendai virus. Nature 270, 614-615 (1977).
84. + cells through interaction with the VH3 region of IgE. J. Immunol. 164, 589-595 (2000).
85. Kulka, M., Alexopoulou, L., Flavell, R. A. & Metcalfe, D. D. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114, 174-182 (2004).
86. Castleman, W. L., Sorkness, R. L., Lemanske, R. F. Jr & McAllister, P. K. Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am. J. Pathol. 137, 821-831 (1990).
87. Sorden, S. D. & Castleman, W. L. Virus-induced increases in bronchiolar mast cells in Brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab. Invest. 73, 197-204 (1995).
88. Sundstrom, J. B. et al. Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood 109, 5293-5300 (2007).
89. Shirato, K. & Taguchi, F. Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology 386, 88-93 (2009).
90. Legrand, L. F., Hotta, H., Hotta, S. & Homma, M. Antibody-mediated enhancement of infection by dengue virus of the P815 murine mastocytoma cell line. Biken J. 29, 51-55 (1986).
91. McLachlan, J. B. et al. Mast cell activators: a new class of highly effective vaccine adjuvants. Nature Med. 14, 536-541 (2008).
92. McGowen, A. L., Hale, L. P., Shelburne, C. P., Abraham, S. N. & Staats, H. F. The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine 27, 3544-3552 (2009).
93. Dillon, S. B. & MacDonald, T. T. Limit dilution analysis of mast cell precursor frequency in the gut epithelium of normal and Trichinella spiralis infected mice. Parasite Immunol. 8, 503-511 (1986).
94. Kasugai, T. et al. Infection with Nippostrongylus brasiliensis induces invasion of mast cell precursors from peripheral blood to small intestine. Blood 85, 1334-1340 (1995).
95. Madden, K. B. et al. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147, 1387-1391 (1991).
96. Lantz, C. S. et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93 (1998).
97. Matsuda, H. et al. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J. Immunol. 144, 259-262 (1990).
98. Furuta, T., Kikuchi, T., Iwakura, Y. & Watanabe, N. Protective roles of mast cells and mast cell-derived TNF in murine malaria. J. Immunol. 177, 3294-3302 (2006).
99. Malaviya, R., Ikeda, T. & Abraham, S. N. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol. Lett. 91, 103-111 (2004).
100. Xu, X. et al. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 173, 219-225 (2006).